Full-Time

Quality Assurance Technician

Posted on 9/26/2025

Green Thumb Industries

Green Thumb Industries

1,001-5,000 employees

Retail cannabis products across multiple brands

No salary listed

New Haven, CT, USA

In Person

Category
QA & Testing (1)
Requirements
  • Must pass all required background checks
  • Must be and remain compliant with all legal or company regulations for working in the industry
  • Must possess valid driver’s license
  • Must be a minimum of 21 years of age
  • Must be approved by state badging agency to work in cannabis industry
Responsibilities
  • * Supports the Quality Department and ensures all employees understand and follow all standard operating procedures (SOPs).
  • * Perform incoming inspections of materials received and ensure compliance with all specifications and requirements.
  • * Execute in-process and finished product sampling as required.
  • * Conducts positive release of all finished goods, which includes review of in-process batch documentation, packaging, labeling, logbooks, test results against internal specifications, and other production paperwork as required.
  • * Ensures good documentation practices are followed and all records are filed and maintained accordingly.
  • * Assist with segregation, control, and disposition of non-conforming product.
  • * Identify, recommend, and perform quality training as needed.
  • * Ensure maintenance and control of production quality records.
  • * Assist Quality Manager and production personnel in the investigation of root causes of quality incidents and non-conformances and assist with documenting and performing corrective and preventative actions.
  • * Continually study the existing quality system and make recommendations for improvements.
  • * Perform improvement projects as identified.
  • * Monitors compliance to established current Good Manufacturing Practice (GMP) guidance.
  • * Expected to adhere to safe work practices, follow general GMP and food safety guidelines, maintain sanitary conditions and ensure that product quality is maintained. Report to management any conditions or practices that may adversely affect product safety, product quality or personnel safety.
  • * Maintain and foster a positive work atmosphere.
  • * Perform pre-operation inspection and sanitation verification of production areas as required.
  • * Perform allergen and environmental swabbing activities as needed.
  • * Performs other duties as assigned.
Desired Qualifications
  • Associate degree in a related field preferred, or equivalent combination of education, training and/or experience.
  • Prior experience in regulated industry in healthcare, medical devices, pharmaceutical, consumer packaged goods (food), or cannabis is highly desired.
  • Food and Drug Administration (FDA), Good Manufacturing Practices (GMP), Safe Quality Food (SQF) and Hazard Analysis Critical Control Point (HACCP) experience is highly desired.
  • Strong experience with product sampling and inspection.
  • Must have the knowledge and skills required to work in a fast paced and challenging environment
  • Must be able to work variable day shifts dependent on business need
  • Ability to follow written procedures and monitor others for adherence to written procedures.
  • Ability to work independently, handle multiple tasks and problem solve effectively.
  • Exceptional computer skills in Microsoft® Office Suite (Access, Excel, Outlook, PowerPoint, Publisher, Word).
  • Should have a solid understanding of the Cannabis laws, rules and regulations or a passion to further their understanding and knowledge of the industry and the laws.
  • Prior cannabis experience not required
Green Thumb Industries

Green Thumb Industries

View

Green Thumb Industries (GTI) operates in the legal cannabis market, growing a family of brands that make edibles, flowers, and concentrates for adults 21+ and qualified medical patients. Its products are sold through its own national retail stores and other channels, with stores that educate customers through People Care Specialists who guide exploration of products. GTI differentiates itself with a diverse brand lineup, in-store education-focused experiences, and a focus on consistent quality, including products like incredibles confections that meet strict food industry standards. Its goal is to improve well-being and community support by providing accessible, high-quality cannabis products and informative retail experiences.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $300 million with $94 million Normalized EBITDA and $76 million cash flow.
  • Flat $70 million annual RYTHM licensing fee from April 1 boosts earnings on incremental revenue.
  • Cannabis rescheduling to Schedule III eliminates 280E, slashing effective tax rate to 21%.

What critics are saying

  • Teamsters strike disrupts RISE dispensaries and manufacturing, raising costs in 3-6 months.
  • Trulieve's 169 Florida stores erode Green Thumb's 22 locations market share in 6-12 months.
  • Pricing pressures cause mid-single digit Q1 2026 revenue decline in Florida and New York.

What makes Green Thumb Industries unique

  • Green Thumb Industries fully pays 280E taxes, retaining 60% of cash flow unlike peers.
  • GTI operates 77 RISE dispensaries and 17 manufacturing facilities across 15 markets.
  • Portfolio includes branded products like RYTHM, Dogwalkers, and incredibles confections.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
AD HOC NEWS Portal Aktiengesellschaft
Mar 30th, 2026
TerrAscend stock: navigating the evolving cannabis landscape for North American investors.

TerrAscend stock: navigating the evolving cannabis landscape for North American investors. 30.03.2026 - 19:22:34 | ad-hoc-news.de TerrAscend Corp. (ISIN: CA88160R1087) operates as a leading cannabis cultivator and retailer with a strong footprint in key North American markets. Investors eye its growth potential amid regulatory shifts and market consolidation. This analysis explores what drives the stock today and key factors to monitor. TerrAscend Corp. stands as a prominent player in the North American cannabis industry, focusing on cultivation, processing, and retail distribution. Listed under ISIN CA88160R1087 on the Canadian Securities Exchange as TSND, the company targets vertically integrated operations to capture value across the supply chain. For North American investors, TerrAscend represents exposure to the burgeoning legal cannabis market, where evolving regulations and consumer trends shape long-term opportunities. As of: 30.03.2026 By Elena Voss, Senior Financial Editor at NorthStar Market Insights: TerrAscend embodies the resilience of cannabis operators adapting to regulatory maturation in North America. Company overview and business model. Official source All current information on TerrAscend directly from the company's official website. TerrAscend Corp. maintains a vertically integrated business model that spans cultivation, manufacturing, distribution, and retail. This structure allows the company to control quality from seed to sale, a critical advantage in a fragmented industry. Operations center on high-quality flower production and branded products like cookies and concentrates, appealing to recreational and medical consumers alike. The company's portfolio includes state-of-the-art cultivation facilities designed for efficiency and scalability. By focusing on premium genetics and sustainable practices, TerrAscend differentiates itself from commodity producers. Retail banners such as Apothecarium provide direct-to-consumer channels, enhancing brand loyalty and margins. Geographically, TerrAscend holds licenses in multiple U.S. states including New Jersey, Pennsylvania, and California, alongside Canadian operations. This multi-jurisdictional presence mitigates regional risks while positioning the company for national expansion as barriers lower. Investors value this footprint for its potential to capitalize on population density and market maturity. Market position and competitive landscape. Sentiment and reactions In the competitive cannabis sector, TerrAscend competes with multi-state operators (MSOs) like Curaleaf and Green Thumb Industries. Its edge lies in operational efficiency and a focus on East Coast markets, where adult-use legalization drives demand. The company's wholesale distribution strengthens ties with third-party retailers, expanding reach without heavy capital outlay. Market share gains depend on execution in high-growth states. Pennsylvania and New Jersey represent significant opportunities due to large populations and recent regulatory openings. TerrAscend's ability to secure additional licenses or partnerships will define its trajectory against larger peers. Branding plays a pivotal role, with in-house lines gaining traction among discerning consumers. As the industry shifts from price wars to premiumization, TerrAscend's product innovation supports sustained revenue growth. North American investors monitor these dynamics for signs of margin expansion. Sector drivers and regulatory environment. The cannabis sector benefits from ongoing legalization trends across North America. In the U.S., over 24 states have recreational markets, with more under consideration. Canada, post-2018 legalization, sees maturing recreational sales alongside medical stability. TerrAscend navigates a complex regulatory landscape, including state-specific compliance and federal restrictions. Potential U.S. rescheduling of cannabis to Schedule III could unlock banking access and tax relief, benefiting operators like TerrAscend. Investors watch federal progress closely for industry-wide catalysts. Supply chain constraints and potency caps influence production strategies. TerrAscend adapts by optimizing yields and diversifying formats like edibles and vapes. Broader economic factors, such as inflation and consumer spending, also impact discretionary purchases like cannabis. Financial strategy and growth catalysts. TerrAscend pursues a disciplined financial strategy emphasizing cash flow generation and debt reduction. Investments in automation enhance cultivation efficiency, lowering costs per gram. Retail expansion through acquisitions or organic growth bolsters recurring revenue. Key catalysts include license approvals and market share capture in new jurisdictions. Vertical integration minimizes intermediary costs, supporting profitability as wholesale prices stabilize. The company's balance sheet strength allows flexibility for opportunistic moves. For growth-oriented investors, TerrAscend offers leverage to sector tailwinds without excessive dilution risks. Management's track record in integrations signals capability to execute amid consolidation waves sweeping the industry. Investor relevance for North americans. Further developments, updates, and context on the stock can be explored quickly through the linked overview pages. North American investors find TerrAscend appealing due to its U.S.-centric operations, offering indirect exposure to domestic legalization without direct state-level investments. Canadian listing provides liquidity and transparency via SEDAR filings. Currency dynamics between CAD and USD add a layer for U.S. holders. The stock aligns with portfolios seeking high-beta growth in emerging markets. Dividend policies remain secondary to reinvestment, suiting long-term holders. ETF inclusions could boost visibility and trading volume. Performance benchmarks against the MOC index highlight relative strength during sector recoveries. Investors assess TerrAscend for its role in diversified cannabis allocations. Risks and open questions. Regulatory delays pose the primary risk, with federal reform timelines uncertain. State-level enforcement variations could disrupt operations. Intense competition pressures pricing power, especially in oversupplied markets. Execution risks in scaling retail and cultivation persist. Economic downturns may curb consumer spending on non-essentials. Investors should watch cash burn rates and debt covenants closely. Open questions include acquisition pipelines and international ambitions. Path to positive free cash flow remains pivotal. Dilution from financings could impact per-share value if markets weaken. Supply disruptions from weather or input costs add volatility. Black market persistence challenges legal sales growth. North American investors prioritize management's navigation of these hurdles. Disclaimer: Not investment advice. Stocks are volatile financial instruments. Trojaner, Phishing, Datenklau: So schützen Android-Experten ihre eigenen Geräte. Gratis-Sicherheitspaket vom 03. April: Jeden Tag werden 560.000 neue Schad-Apps für Android entdeckt - viele tarnen sich als harmlose Downloads. Die IT-Experten von Computerwissen haben ihre bewährtesten Schutzmaßnahmen in einem kostenlosen Paket zusammengestellt: 5 konkrete Anleitungen, die jeder Android-Nutzer in unter 10 Minuten umsetzen kann. Ohne technische Vorkenntnisse. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen - dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren. Für. Immer. Kostenlos. CA88160R1087 | TERRASCEND | boerse | 69031577 | bgmi

Yahoo Finance
Mar 18th, 2026
Green Thumb Industries down 17% YTD as pricing pressures persist despite $295M cash flow

Green Thumb Industries, one of the largest US cannabis operators by market capitalisation, has seen its shares fall 17% year to date, reflecting regulatory challenges and competition rather than company-specific issues. Despite a brief sentiment boost from President Trump's push for federal marijuana rescheduling, broader reforms remain necessary for meaningful change. The company reported revenues of approximately $1.2 billion for 2025, up 3.4% year over year, driven by retail cannabis sales and expansion in markets including Minnesota, Florida and New York. Its retail footprint expanded to 113 stores. Green Thumb generated $295 million in operating cash flow, up roughly $100 million year over year. However, management expects first-quarter 2026 revenues to decline mid-single digits sequentially due to pricing pressure in mature markets.

Yahoo Finance
Mar 8th, 2026
Green Thumb Industries posts $83.2M Q4 profit but warns Q1 revenue to drop mid-single digits

Green Thumb Industries reported fourth-quarter 2025 sales of $311.13 million and net income of $83.2 million, with full-year 2025 sales reaching $1.18 billion and net income of $114.15 million, all exceeding prior year figures. However, the cannabis company warned that first-quarter 2026 revenue would decline by mid-single digits sequentially due to pricing pressure and seasonality. The company recently increased its syndicated credit facility by $50 million to $189 million, providing additional financial flexibility. Whilst Green Thumb's profitability remains strong, the near-term outlook reflects ongoing sector-wide price compression and regulatory uncertainty. The earnings highlight a tension between improving margins and softening revenue growth, with analysts projecting $1.3 billion revenue and $141.9 million earnings by 2028, requiring 4.2% annual revenue growth.

Green Thumb Industries
Feb 21st, 2026
Green Thumb Industries Announces an Additional $50 Million Senior Debt Financing - Fri, 02/20/2026 - 07:00

Five-year syndicated credit facility at an industry-leading rate of SOFR+500 CHICAGO and VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc.  (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods

Stockwatch
Feb 20th, 2026
Green Thumb Industries secures $50M debt facility at SOFR+500, expanding total credit to $189M

Green Thumb Industries has increased its existing syndicated credit facility by $50 million, bringing the total to $189 million. The five-year facility, led by Valley National Bank, carries an interest rate of SOFR+500 basis points and matures on 11 September 2029. The Chicago-based cannabis company will use the proceeds for general corporate purposes, potential strategic investments and working capital requirements. No equity was issued to participating banks in the syndication. Green Thumb, which operates the RISE Dispensaries chain and manufactures branded cannabis products including RYTHM and Dogwalkers, has 20 manufacturing facilities and over 100 retail stores across 14 US markets, employing approximately 5,000 people.

INACTIVE